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Background. In the period immediately after birth, preterm infants are highly susceptible to lung injury. Early nasal
continuous positive airway pressure (ENCPAP) is an attempt to avoid intubation and may minimize lung injury. In contrast,
ENCPAP can fail, and at that time surfactant rescue can be less effective. Objective. To compare the pulmonary clinical
course and outcome of very preterm infants (gestational age 25–32 weeks) with respiratory distress syndrome (RDS) who
started with ENCPAP and failed (ECF group), with a control group of infants matched for gestational age, who were directly
intubated in the delivery room (DRI group). Primary outcome consisted of death during admission or bronchopulmonary
dysplasia (BPD). Results. 25 infants were included in the ECF group and 50 control infants matched for gestational age were
included in the DRI group. Mean gestational age and birth weight in the ECF group were 29.7 weeks and 1,393 g and in the
DRI group 29.1 weeks and 1,261 g (p=NS). The incidence of BPD was significantly lower in the ECF group than in the DRI
group (4% vs. 35%; P,0.004; OR 12.6 (95% CI 1.6–101)). Neonatal mortality was similar in both groups (4%). The incidence of
neonatal morbidities such as severe cerebral injury, patent ductus arteriosus, necrotizing enterocolitis and retinopathy of
prematurity, was not significantly different between the two groups. Conclusion. A trial of ENCPAP at birth may reduce
the incidence of BPD and does not seem to be detrimental in very preterm infants. Randomized controlled trials are
needed to test whether early respiratory management of preterm infants with RDS plays an important role in the
development of BPD.
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INTRODUCTION
Early respiratory management (ERM) specifies ventilatory support
from birth until stabilization during the first days of life. ERM
starts with resuscitation in the delivery room (DR) and is primarily
based on adequate ventilation. However, the recently updated
international guidelines on neonatal resuscitation do not provide
specific recommendations on how to provide ERM in very
preterm infants due to lack of data.[1] Various ERM strategies are
currently used to compensate for inadequate respiratory drive,
surfactant deficiency and/or disturbances in the reabsorption of
lung liquid after birth. Early nasal continuous positive airway
pressure (ENCPAP), started directly after birth, is a gentle and
effective non-invasive attempt to support non-compliant lungs.[2–
6] It has been shown in animal studies that ENCPAP minimizes
lung injury after preterm birth.[7,8] During the immediate
postnatal period the preterm, surfactant-deficient lung is highly
susceptible to tissue injury and an exaggerated, unchecked inflam-
matory reaction can be triggered with the first manual breaths
during resuscitation.[9–13] Several cohort studies report less
requirement of mechanical ventilation when ENCPAP is used.[14]
Nonetheless, a considerable percentage of preterm infants with
RDS fails ENCPAP and requires intubation and mechanical
ventilation during the first days of life.[15,16] During this time
period a potential improvement of lung function by surfactant
treatment may have been missed as surfactant-deficient preterm
infants respond better to surfactant treatment when it is given early
in the course of their disease.[17,18]
The aim of this case-control study was to compare the pulmon-
ary course and outcome of very preterm infants with RDS who
failed ENCPAP (ECF group) and a control group of infants,




All inborn very preterm infants with a gestational age#32 weeks
admitted to the neonatal intensive care unit of the Leiden
University Medical Center from January 2003 until December
2005 were identified. Limits of viability in the Netherlands are set
at 25 weeks’ gestation. Clinical data were collected from the
hospital records. All infants with RDS who were supported with
ENCPAP but failed and were intubated and ventilated within
72 hours after birth (ENCPAP failure=ECF group) were selected
for the study group. Each infant in the ECF group was matched
for gestational age (61 week of gestation) with the next two
consecutively born infants born with RDS who were intubated
in the delivery room (delivery room intubation=DRI group).
Diagnosis of RDS was based on clinical symptoms and chest
X-ray findings. The following perinatal data were collected: birth
weight, gestational age, gender, race, singleton or twin, maternal
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PLoS ONE | www.plosone.org 1 February 2007 | Issue 2 | e192pregnancy disease, preterm premature rupture of the membranes,
signs of chorioamnionitis (defined as maternal fever with at least
one of the following symptoms: leucocytosis, tenderness of the
uterus, fetal tachycardia, foul-smelling amniotic fluid), mode of
delivery, intra-uterine growth retardation, antenatal steroids
(defined as any administration of steroids irrespective of comple-
tion of therapy), umbilical arterial pH, resuscitation in the DR
(none, oxygen administration, positive pressure ventilation with
mask and bag, intubation and mechanical ventilation), 5 min
Apgar score. Postnatal data collection included: ENCPAP (defined
as NCPAP support within 15 minutes after admission to the
neonatal intensive care unit), intubation within 72 hours, time and
cause of intubation, clinical signs of RDS and staging by chest
X-ray, duration of mechanical ventilation (first period and total
period), type of ventilation (conventional ventilation only, rescue
high frequency oscillation), surfactant treatment, administration of
postnatal steroids, and occurrence of air leaks.
Primary outcome consisted of death during admission or
bronchopulmonary dysplasia (BPD) based on the NICHD defini-
tion.[19] Secondary outcome was based on the presence of cerebral
pathology detected by cranial ultrasound, retinopathy of pre-
maturity, patent ductus arteriosus, and necrotizing enterocolitis.
Respiratory management
If respiration was insufficient in the delivery room, positive-
pressure ventilation was started with a self-inflating bag and mask
during 30 seconds. At first inflation, pressures up to 30–40 cmH20
could be given, thereafter not more than 20 cmH2O was allowed.
If signs of respiratory distress persisted, the decision to intubate
and start mechanical ventilation or to start ENCPAP (within
15 minutes) was dependant on RDS severity and clinical judge-
ment of the attending neonatologist. After arrival in the neonatal
intensive care unit, ENCPAP was given with nasopharyngeal tube
or Infant Flow (EME Tricomed, Brighton, UK). CPAP-levels were
titrated from 4 to 8 cmH20 according to the degree of respiratory
distress, assessed by observing the infant’s chest retraction, effort of
breathing, chest radiograph appearance, and oxygen requirement
(stabilize oxygenation until arterial PO2.50 mmHg, while
pH.7.20 and arterial PCO2,60 mmHg). Caffeine or theophyl-
line treatment was started as soon as possible after birth in
neonates,30 weeks of gestation and only after apnea emerged in
more mature infants.
Intubation and mechanical ventilation were initiated when
infants exhibited arterial hemoglobin saturations,88% or arterial
PO2#50 mmHg while receiving FiO2$0.40 (corresponding with
an AaPO2 ratio,0.22) and/or arterial PCO2.60 mmHg,
pH,7.20, or when more than 4 apnea episodes occurred in one
hour or mask ventilation was needed .2 times per hour. Surfact-
ant was given when on mechanical ventilation with a mean airway
pressure x FiO2 ratio.2. Infants with RDS were extubated as
soon as a FiO2,0.3 and a mean airway pressure,7 cmH2O was
reached. Immediately after extubation NCPAP was started using
an infant flow device or nasopharyngeal tube. NCPAP was dis-
continued when the neonate remained stable with a capillary
PCO2,60 mmHg, oxygen saturation.92% without supplemen-
tary O2 and no NCPAP for more than four consecutive hours. No
changes in respiratory management occurred in the study period.
Data analysis
Data are presented as mean6SD or number (percentage) and
were analyzed with SPSS software (SPSS for windows, version
12.0, 2005, Chicago, IL). Analyses compared infants who failed
ENCPAP treatment and were intubated within 72 hours of age
(ECF group) and matched infants who were intubated immedi-
ately in the DR (DRI group). The null hypothesis was that the
ECF group did not have a better pulmonary clinical course and
outcome than the DRI group. The baseline characteristics of the
two groups were compared using Student’s t test for parametric
and the Mann-Whitney U test for non-parametric comparisons for
continuous variables, and the x
2 test for categorical variables.
Reported p-values are two-sided; the level of significance is ,0.05.
RESULTS
Early respiratory management
A total of 268 inborn very preterm infants (gestational age range
between 25 and 32 weeks) were admitted consecutively to the
neonatal intensive care unit between January 1, 2003 and
December 31, 2005. Six infants were excluded because of severe
congenital anomalies of the cardiac or respiratory system or
anomalies incompatible with survival. The remaining 262 infants
had a mean birth weight of 13186385 g, mean gestational age of
29.361.9 weeks, and the mortality rate was 7% (19/262). The
incidence of moderate or severe BPD [19] among survivors was
15% (37/243). ERM of the 262 included infants is shown in
Figure 1. ENCPAP was started after arrival at the NICU in 83/87
(95%) infants and 4 (5%) of them received ENCPAP immediately
in the DR. A nasopharyngeal tube was used 85% of the cases and
an infant flow driver in 15%. There were no statistically significant
differences in clinical failure between the two devices. The dis-
tribution of DRI, ENCPAP and ECF, plotted against gestational
age is shown in Figure 2. Failure of CPAP occurred in 1/9 (11%)
infants,28 weeks, in 15/50 (30%) infants of 28–30 weeks and in
12/30 (40%) infants.30 weeks of gestation. RDS was the
principal cause of ECF (25/28 (89%) infants)
Figure 1. The distribution of need of ventilatory support in very preterm
neonates (25–33 weeks of gestation). ENCPAP=early nasal continuous
positive airway pressure; mask and bag: using a self-inflating bag.
doi:10.1371/journal.pone.0000192.g001
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RDS was diagnosed in 127/262 (48%) very preterm infants. In
42/127 (33%) infants with RDS, ENCPAP was started within
15 minutes after birth, and in 13 of them (31%) mask and bag
ventilation was given in the delivery room. In 25/42 (59%)
infants ENCPAP failed within 72 hours of age and they needed
endotracheal intubation, ventilation and surfactant treatment
(ECF-group) (mean time of intubation 14 hours after birth; range
0.3–65 hours). 83/127 (65%) infants with RDS were immediately
intubated in the delivery room, of this group 50 infants formed the
DRI-group according to described methods. The basic character-
istics of the ECF-group and matched infants in the DRI-group
were not significantly different (Table 1). Table 2 presents the
pulmonary clinical parameters of the ECF and DRI groups. All
patients with RDS intubated within 72 hours received surfactant,
but significant more doses of surfactant were needed in the
DRI-group.
Primary outcome is shown in Table 3. Survivors in the DRI
group had significantly more often moderate to severe BPD at
36 weeks of gestation than survivors in the ECF group. Mortality
was 4% in both groups and all died due to respiratory failure.
Comparison of secondary outcome between the ECF and DRI
groups did not show significant differences in severe intraventi-
cular hemorrhage (.grade 2) (3/24 (12.5%) vs. 3/49 (6.1%)),
cystic periventricular leucomalacia (0/24 (0%) vs. 2/47 (4%)) and
patent ductus arteriosus requiring medical or surgical closure
(5/25 (20%) vs. 15/50 (30%)). Necrotizing enterocolitis requiring
surgery and severe retinopathy of prematurity was absent in both
groups.
DISCUSSION
ENCPAP proved to be a valuable initial ventilatory strategy as
a significant percentage of very preterm infants (33%) was
successfully managed with ENCPAP alone, even extremely
preterm infants (,28 weeks). However, ENCPAP can also fail,
requiring infants to be intubated within 72 hours after birth,
mostly because of RDS. This study shows that infants in the
ENCPAP failure group need less doses of surfactant and have
a lower incidence of BPD compared to the matched DRI-infants.
These findings are in agreement with animal studies, which have
Figure 2. Distribution of delivery room intubation, ENCPAP and ENCPAP-failure plotted against gestational age. DRI=delivery room intubation;
ENCPAP=early continuous positive airway pressure.
doi:10.1371/journal.pone.0000192.g002
Table 1. Comparison of characteristics of infants with RDS
who failed treatment with ENCPAP (ECF) and matched infants










BW, g 13936379 12616395 NS
GA, wk 29.761.6 29.161.6 NS
Gender, male n (%) 9 (36) 27 (54) NS
Umbilical arterial pH 7.2860.13 7.2260.13 NS
Prenatal steroids, n (%) 17 (68) 33 (66) NS
Chorioamnionitis, n (%) 2 (8) 5 (10) NS
PPROM, n (%) 6 (24) 15 (30) NS
Toxaemia, n (%) 6 (24) 16 (32) NS
Fetal distress, n (%) 9 (36 ) 18 (36) NS
IUGR, n (%) 4 (16) 11 (22) NS
Caesarean section, n (%) 12 (48) 24 (48) NS
Apgar, 5 min,7, n (%) 1 (4) 10 (20) NS
Singletons, n (%) 13 (52) 20 (40) NS
BW=birth weight; ENCPAP=early nasal continuous positive pressure;
GA=gestational age; PPROM=preterm premature rupture of the membranes;
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period directly after birth may play an important role in the
development of BPD. [7,9–13,20] A trial of ENCPAP at birth may
be a good alternative for intubation in case of RDS and may
reduce the incidence of BPD. Because the ECF group does not
have more adverse outcomes and complications than the DRI
group, it seems reasonable to avoid or postpone intubation if
possible, as long as early surfactant rescue is given if intubation
becomes mandatory.
Initial and early respiratory management in preterm infants is
a hot topic in neonatology. The IFDAS trial, presented and
published in abstract form, gives a good representation of the main
approaches.[14] Many clinicians advocate elective intubation and
early administration of surfactant.[17,21] Others opt for an
alternative approach of ENCPAP and selective surfactant treat-
ment. Various non-randomized retrospective studies, with or
without historic controls, report lower or no differences in rates of
BPD in centers that try to avoid intubation and ventilation of
preterm infants.[21] However, the inclusion criteria, including
gestational age of the preterm infants, the methods used to deliver
NCPAP, and the levels of CPAP used vary between the studies.
The interpretation of ‘‘early’’ NCPAP varies from starting in the
delivery room directly after resuscitation to starting in the neonatal
intensive care unit when signs of RDS appear.[21] ENCPAP and
selective surfactant is an accepted alternative, but a Cochrane
review of trials of prophylactic (=early) NCPAP recently
concluded that there is currently insufficient information to
evaluate the effectiveness of prophylactic NCPAP in very preterm
infants.[22] Retrospective studies in which ENCPAP is started in
the delivery room have shown a reduction in incidence of
BPD.[3,4,6] To the best of our knowledge, this is the first case-
control study comparing ENCPAP-failure and DR intubation in
case of RDS. Similar to our study, Aly et al. retrospectively
compared outcome of ENCPAP-failure and delivery room intuba-
tion in very preterm infants. However, they did not report the
incidence of RDS in the total group and found, after controlling
for basic characteristics, no difference in outcome, except for more
NEC in the ENCPAP-failure group.[16] We found no significant
differences in secondary outcome, including NEC. Lindner et al.
reported a significant decrease in DR intubation when a new
ventilatory strategy was introduced, consisting of a continuous
prolonged pressure-controlled inflation followed by CPAP at
4–6 cmH2O.[11] Their study was not designed to test the
difference in outcome between direct intubation and ENCPAP-
failure. Nevertheless, in case of RDS, the incidence of BPD was
40% when infants were intubated in the delivery room compared
to 22% when intubated later.[6] In contrast to these reports and
also to our findings, the infant flow driver and surfactant (IFDAS)
trial found no reduction in BPD when ENCPAP was used. Lack of
significance may have been the result of a lack of power due to
randomisation of the 237 infants of 27–29 weeks of gestation to 4
treatment groups. [14]
The period directly after birth is a very vulnerable phase and
unnecessary intubation and ventilation may damage the upper
airway and cause iatrogenic respiratory distress.[13,20]. The use of
a self-inflating bag prior to intubation may also induce lung injury
as PEEP can not be regulated and an accurate peak inspiratory
pressure is difficult to achieve. [23,24] Acute ventilator-induced
lung injury sustained shortly after birth can trigger the in-
flammatory cascade, which may progress to BPD.[7–13] Animals
studies have shown that this inflammatory process may occur with
the first manual breaths during resuscitation and compromise the
effect of subsequent surfactant rescue treatment.[9];[10];[12] Even
administration of prophylactic surfactant does not protect against
the adverse affects of large lung inflations at birth.[11] In addition,
lung injury after birth can be minimized by using ENCPAP
instead of intubation and mechanical ventilation.[7,8]
Symptoms of respiratory distress at birth in preterm infants may
solely be due to their efforts to clear fluid from their lungs. Their
ability to do so can be limited by surfactant deficiency and their
soft and flexible chest wall makes preterm infants less able to
generate sufficiently high pressures to achieve effective lung
expansion.[25,26] Nevertheless, expectant management (without
direct intubation) may show that some preterm neonates are able
to manage this with NCPAP assistance only. Once the alveoli are
aerated, breathing needs less effort and distress symptoms may
diminish. Some preterm infants who are intubated and ventilated
in the DR may have had respiratory distress appropriate to
a transitory phase, which eventually led to pulmonary complica-
tions due to ‘‘iatrogenic’’ RDS.
Compared to other reports, we found a higher percentage of
ENCPAP-failure (32%) in our study, mostly due to RDS
(89%).[4,15,16,27] This difference may be due to the lower
threshold for intubation and surfactant used at our institution.
Preterm infants with RDS at our neonatal intensive care unit
are intubated and ventilated as soon as the FiO2 is.40% or
PaCO2.8.0 kPa and a maximum ENCPAP (8 cmH2O) is
reached. Treatment with surfactant is considered when mean
airway pressure x FiO2.2. In other reports, the FiO2 threshold
for intubation was higher and varied from $0.6 to 1.0.[4,15,
16,27] The threshold for intubation and surfactant treatment
when RDS has been established is an important issue. Pro-
phylactic or early surfactant treatment of infants requiring
mechanical ventilation is more effective than late rescue
Table 2. Pulmonary characteristics of neonates with RDS who
failed ENCPAP treatment (ECF) and matched infants who were
intubated in the DR (DRI).
......................................................................
Pulmonary clinical course
parameters ECF n=25 DRI n=50
Univariate
analysis (P)
Surfactant, n doses 1.060.5 1.660.8 ,0.0005
HFOV rescue, n (%) 3 (12) 15 (30) NS
Total period of mechanical
ventilation, days
3.965.6 7.069N S
Pneumothorax, n (%) 1 (4) 3 (6) NS
Dexamethasone, n (%) 1 (4) 7 (15) NS
ENCPAP=early nasal continuous positive pressure; RDS=respiratory distress






















































Table 3. Primary outcome of infants who failed ENCPAP
treatment (ECF) and matched infants who were intubated in
the delivery room (DRI).BPDmod-sev=moderate and severe
bronchopulmonary dysplasia.
......................................................................
Primary outcome ECF n=25 DRI n=50 Univariate analysis (P)
BPD mild 7 11 NS
BPD moderate 1 14 0.01
BPD severe 0 3 NS
BPDmod-sev, n (%) 1 (4) 17 (35) 0.004 OR 12.6
(95% CI 1.6–101)
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PLoS ONE | www.plosone.org 4 February 2007 | Issue 2 | e192treatment.[17,18,28] However, with prophylactic treatment a
certain amount of (surfactant sufficient) preterm infants are over-
treated. Conversely, late rescue (FiO2$0.6) with surfactant in an
infant who is quickly deteriorating because of RDS may be
disadvantageous and deleterious.[29,30] Another explanation for
the higher incidence of ENCPAP-failure in this study is the
starting point of ENCPAP. Even if the lung is opened in the DR,
with or without the help of mask and bag ventilation, a non-
compliant surfactant-deficient lung has a tendency to collapse and
lung volume is not maintained if CPAP/PEEP is not given directly
to keep the lung open. In most infants in our study, ENCPAP was
only started after transportation to the neonatal intensive care unit,
which is adjacent to the delivery room, allowing the lung to
collapse.
We are aware that the retrospective nature of this case-control
study forms an important limitation. A selection-bias may have
occurred in the DR when the decision was made to intubate or not
and infants in the DRI-group may represent the sickest neonates
with more severe RDS and higher risk for BPD. Although we
found no significant differences in pulmonary clinical course
parameters between the ECF and DRI groups, lack of significance
can be explained by the small sample size of the study.
In summary, this study suggests that a trial of ENCPAP at birth
is not detrimental and may be justified in case of RDS, providing
early surfactant rescue is given if the infant needs to be intubated
and ventilated. Based on this study, randomized controlled trials
are warranted to test the hypothesis that early respiratory
management of preterm neonates with RDS plays an important
role in the development of BPD. Recently published or started
randomized trials of ENCPAP are few.[31,32] In 2005 we started
a randomized controlled trial (EFURCI-trial, Early Functional
Residual Capacity Intervention, ISRCTN 12757724) to investi-
gate in preterm infants#32 weeks whether sustained inflation with
a mechanical device (NeopuffH) and ENCPAP will be a more
effective management strategy in very preterm neonates than
conventional intervention and will reduce the requirement for
mechanical ventilation and surfactant treatment.
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